1. Home
  2. TTC vs SYRE Comparison

TTC vs SYRE Comparison

Compare TTC & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Toro Company (The)

TTC

Toro Company (The)

HOLD

Current Price

$98.23

Market Cap

9.3B

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$103.42

Market Cap

8.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTC
SYRE
Founded
1914
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Tools/Hardware
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.3B
8.5B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
TTC
SYRE
Price
$98.23
$103.42
Analyst Decision
Buy
Strong Buy
Analyst Count
4
12
Target Price
$104.00
$85.08
AVG Volume (30 Days)
550.5K
1.0M
Earning Date
06-04-2026
05-08-2026
Dividend Yield
1.66%
N/A
EPS Growth
N/A
N/A
EPS
2.18
N/A
Revenue
$2,618,650,000.00
N/A
Revenue This Year
$6.13
N/A
Revenue Next Year
$4.45
N/A
P/E Ratio
$45.38
N/A
Revenue Growth
4.53
N/A
52 Week Low
$67.64
$14.51
52 Week High
$105.19
$108.14

Technical Indicators

Market Signals
Indicator
TTC
SYRE
Relative Strength Index (RSI) 63.12 58.74
Support Level $91.66 $92.37
Resistance Level $102.32 N/A
Average True Range (ATR) 2.31 5.52
MACD 0.61 -0.23
Stochastic Oscillator 94.65 74.41

Price Performance

Historical Comparison
TTC
SYRE

About TTC Toro Company (The)

The Toro Co designs, manufactures, markets, and sells professional turf maintenance equipment and services; turf and agricultural irrigation systems; landscaping equipment and lighting products; snow and ice management equipment; construction equipment; and residential yard and snow thrower products. The company operates through Professional and Residential segments, with the Professional segment serving commercial, agricultural, and construction customers and generating the majority of revenue, while the Residential segment focuses on homeowners. Its products are sold through distributors, dealers, retailers, rental centers, and direct channels, with the United States as its primary revenue-generating market.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: